Pirapon June Ohata , Stephen J. Kerr , Sasiwimol Ubolyam , Chavalun Ruengpanyathip , Napon Hiranburana , Hay Mar Su Lwin , Win Min Han , Akarin Hiransuthikul , Wipaporn Natalie Songtaweesin , Yanisa Jarusyingdumrong , Thanyawee Puthanakit , Opass Putcharoen , Gompol Suwanpimolkul & Anchalee Avihingsanon
Published Online: 21 Apr 2026 | https://doi.org/10.1080/17460794.2026.2660598
Although substantial progress has been achieved through the scale-up of antiretroviral therapy (ART), the HIV epidemic in the Asia-Pacific region remains characterized by late presentation, ongoing stigma, and structural inequities in access to care. At the same time, people with HIV (PWH) are aging, resulting in a growing burden of multimorbidity and increasingly complex clinical needs. The Bangkok Symposium International Symposium on HIV Medicine convened regional and international experts to review recent scientific advances and implementation challenges shaping the future of HIV prevention and treatment, with particular emphasis on long-acting agents, differentiated care models, and diagnostic and digital innovations.
Keywords: HIV, long-acting treatment, long-acting PrEP, co-infection, drug resistance, comorbidities, mHealth
Read more: Future Medicine
